Recombinant Pardachirus pavoninus Pardaxin P-3

What is the structural composition of Pardaxin P-3 from Pardachirus pavoninus?

Pardaxin P-3 is one of three ichthyotoxic peptides (P-1, P-2, and P-3) isolated from the defense secretion of the sole fish Pardachirus pavoninus. Like other pardaxins, P-3 consists of 33 amino acid residues with a distinctive structural organization characterized by a hydrophilic carboxyl terminal region and a predominantly hydrophobic remainder, giving it strong surfactant properties . This amphipathic structure is critical for its biological activities. The peptide begins with glycine (G) and ends with glutamic acid (E), which is why pardaxins are sometimes referred to as GE33 . The peptide's amphipathic nature allows it to interact with biological membranes, contributing to its antimicrobial and ichthyotoxic activities .

How does Pardaxin P-3 differ from other Pardaxin variants?

The Pardaxin family consists of several variants, primarily P-1, P-2, P-3 from Pardachirus pavoninus and P-4 and P-5 from Pardachirus marmoratus. These peptides share highly homologous sequences but differ at specific amino acid positions. Particularly, the variations occur at positions 5, 14, and 31 in the amino acid sequence . These subtle differences in amino acid composition can significantly impact their biological activities and specificity. Despite these variations, all pardaxin peptides maintain their fundamental amphipathic structure with 33 amino acid residues . These structural differences may explain variations in antimicrobial spectra, potency, and selectivity among the different pardaxin variants.

What expression systems have been successfully used for recombinant production of Pardaxin?

While the search results don't specifically mention expression systems for Pardaxin P-3, they provide insights into recombinant production of similar antimicrobial peptides. Pichia pastoris has been used as an expression system for the production of recombinant proteins similar to pardaxin . The methodology typically involves:

• Construction of an expression vector containing the pardaxin gene

• Transformation of the expression host (e.g., P. pastoris SMD1168 strain)

• Selection of transformants with multiple integrated copies using antibiotic resistance

• Culturing the selected clones in appropriate medium for protein expression

For example, the expression plasmid can be designed with the pardaxin gene cloned downstream from a signal peptide (like S. cerevisiae α factor) to facilitate secretion . Another potential system is the Escherichia coli expression system, which has been successfully used for the production of recombinant antimicrobial peptides such as epinecidin-1 .

What are the antimicrobial properties of Pardaxin P-3?

Pardaxin P-3, like other pardaxins, demonstrates potent antimicrobial activity against both gram-negative and gram-positive bacteria . Its mechanism of action primarily involves disruption of the bacterial membrane, which leads to cell death. The amphipathic nature of pardaxin enables it to insert into bacterial membranes, forming pores that compromise membrane integrity . This membrane-disrupting mechanism makes the development of resistance less likely compared to conventional antibiotics that target specific metabolic pathways. Although highly effective as an antimicrobial agent, pardaxin also shows significant hemolytic activity against human red blood cells, which is an important consideration for potential therapeutic applications .

How does the mechanism of action of Pardaxin P-3 compare to other antimicrobial peptides?

• Initial electrostatic interaction with the negatively charged bacterial membrane

• Insertion of the hydrophobic region into the membrane

• Formation of pores or channels that disrupt membrane integrity

• Resulting cellular content leakage and eventual cell death

This membrane-disrupting mechanism is common among many antimicrobial peptides but can vary in specificity and efficiency depending on the peptide's structure and composition .

What are the optimal conditions for expressing recombinant Pardaxin P-3 in heterologous systems?

Based on studies with similar antimicrobial peptides, the optimal conditions for expressing recombinant Pardaxin P-3 would likely include:

• Selection of an appropriate expression host: Pichia pastoris has been shown to be effective for expressing similar peptides, particularly when glycosylation is desired .

• Temperature control: Typically, initial growth at 30°C followed by induction at lower temperatures (20-25°C) to enhance proper folding.

• Medium composition: For P. pastoris expression, Buffered Glycerol-complex Medium (BMGY) for growth followed by Buffered Methanol-complex Medium (BMMY) for induction has proven effective .

• Induction parameters: For methanol-inducible promoters like AOX1 in P. pastoris, addition of 0.5-1% methanol every 24 hours during the induction phase.

• pH control: Maintaining pH between 5.5-6.0 to enhance secretion and reduce proteolysis.

When designing the expression construct, it's important to consider the inclusion of a signal sequence for secretion and appropriate purification tags that can be removed without affecting the peptide's activity .

How does glycosylation affect the activity and stability of recombinant Pardaxin?

Glycosylation can significantly impact the properties of antimicrobial peptides like Pardaxin. The search results indicate that glycosylation occurs at the level of the propeptide in similar recombinant proteins . This post-translational modification can affect:

• Stability: Glycosylation typically enhances the stability of peptides by protecting them from proteolytic degradation.

• Activity: The presence of glycans may alter the interaction of Pardaxin with bacterial membranes, potentially affecting its antimicrobial potency.

• Activation kinetics: Research on similar proteins shows that glycosylation of the propeptide can influence the zymogen activation mechanism .

• Immunogenicity: Glycosylation patterns can affect how the immune system recognizes and responds to the peptide.

Studies have demonstrated that the recombinant zymogen can be glycosylated at the propeptide level, and this modification plays a role in the activation process . For researchers working with recombinant Pardaxin, it may be worthwhile to investigate both glycosylated and non-glycosylated forms to determine the optimal version for specific applications.

What is the mechanism behind Pardaxin's selective cytotoxicity toward cancer cells?

Pardaxin has demonstrated selective anticancer activity through multiple mechanisms. Research indicates that Pardaxin selectively targets cancer cells in an electrostatic manner, triggering several cellular responses that lead to apoptosis . The mechanism includes:

• Production of reactive oxygen species (ROS), inducing oxidative stress.

• Triggering unfolded protein response (UPR).

• Activation of signal transduction pathways including JNK/c-Jun and PERK/eIF2α/CHOP.

• Caspase activation and AIF-dependent apoptotic events.

• Loss of mitochondrial membrane potential.

• Decrease of RhoGDI, which is thought to induce initial morphological changes of apoptosis by regulating actin polymerization.

• Chromatin condensation.

Additionally, Pardaxin selectively triggers cancer cell death through a mechanism involving endoplasmic reticulum targeting and c-FOS induction. Transcriptome analysis has revealed that Pardaxin induces the gene encoding c-FOS, an AP-1 transcription factor, which plays a crucial role in mediating cell death . Overexpression of c-FOS causes a dramatic increase in cell death, while knockdown of c-FOS induces Pardaxin resistance, as observed in both in vitro cell models and in vivo applications .

How can protein engineering be used to enhance Pardaxin P-3's therapeutic potential?

Protein engineering approaches can be employed to enhance Pardaxin P-3's therapeutic potential by:

• Reducing hemolytic activity: Modifying specific amino acid residues involved in interaction with eukaryotic cell membranes while preserving those critical for bacterial membrane disruption.

• Enhancing stability: Introducing disulfide bonds or using other stabilizing modifications to increase the peptide's half-life in biological fluids.

• Improving selectivity: Engineering the peptide to interact more specifically with cancer cell membranes or bacterial pathogens of interest.

• Optimizing pharmacokinetics: Adding modifications that improve bioavailability, tissue distribution, or reduce rapid clearance.

• Creating fusion proteins: Developing Pardaxin fusion constructs similar to the epinecidin-1/DsRed fusion protein, which maintained strong antibacterial activity .

Researchers could employ site-directed mutagenesis to systematically modify specific residues and evaluate the resulting effects on activity and selectivity. Computational modeling based on Pardaxin's amphipathic structure could guide these modifications to predict their impact before experimental validation.

What is the role of the propeptide region in the activation and function of Pardaxin?

While the search results don't specifically discuss Pardaxin's propeptide, information about similar proteins suggests important roles for propeptide regions. Based on studies of Der p 3, another protein synthesized as a zymogen (proDer p 3), propeptides typically serve several functions:

• Proper folding: Propeptides often assist in the correct folding of the mature protein, ensuring it adopts the appropriate conformation .

• Inhibition of premature activity: The propeptide may inhibit the activity of the mature peptide until it reaches its target location.

• Targeting: Propeptides can contain signals that direct the protein to specific cellular compartments.

• Regulation of activation: The mechanism of propeptide removal can be a regulated process, ensuring the peptide is only activated under appropriate conditions.

In some cases, the propeptide can act as an inhibitor of the mature peptide's activity. Research on similar proteins has shown that synthetic propeptides can inhibit the enzymatic activity of the mature protein . The activation of the zymogen (removal of the propeptide) may involve specific proteases or environmental conditions, which represents an important regulatory mechanism for the peptide's function.